What are the approaches to performing an inferior hypogastric plexus block?

Approaches to the Inferior Hypogastric Plexus Block

The inferior hypogastric plexus can be accessed via three primary approaches: transsacral (most commonly described), coccygeal transverse, and postero-median transdiscal, with the transsacral approach being the most established technique for treating cancer-related lower pelvic and perineal pain. 1, 2

Primary Indication

The inferior hypogastric plexus block is specifically indicated for lower pelvic visceral pain and perineal pain caused by malignancy, particularly when patients experience inadequate pain relief despite systemic opioid therapy or intolerable side effects from opioid escalation. 3, 4

Technical Approaches

1. Transsacral Approach (Most Established)

• Technique: A spinal needle is passed through the sacral foramen bilaterally under fluoroscopic guidance to reach the pre-sacral inferior hypogastric plexus. 1, 2
• Neurolytic agent: 6-8 mL of 10% phenol injected bilaterally. 1
• Evidence: Demonstrated pain reduction from mean VAS scores of 7.22 ± 1.31 to 4.06 ± 1.73 at one week, with corresponding reduction in morphine consumption from 106.67 ± 32.90 mg to 61.67 ± 40.48 mg. 1
• Safety profile: No complications or serious side effects reported in published series. 1, 2
• Requirements: High degree of familiarity with sacral anatomy, refined needle steering technique, and expertise in fluoroscopy. 2

2. Coccygeal Transverse Approach

• Technique: Alternative approach using a transverse trajectory from the coccyx to access the inferior hypogastric plexus. 5
• Advantage: Avoids some disadvantages of the transsacral approach, though specific comparative data is limited. 5
• Evidence: Case report level evidence only; requires further validation. 5

3. Postero-Median Transdiscal Approach (Combined Technique)

• Technique: Access through the L5-S1 interdiscal space, advancing the needle through the disc under lateral fluoroscopic control until loss of resistance is achieved. 6, 7
• Neurolytic agent: 10 mL of 10% phenol in saline for superior hypogastric plexus component. 6
• Often combined with: Ganglion impar block via trans-sacrococcygeal approach (4-6 mL of 8% phenol) for comprehensive pelviperineal pain coverage. 6
• Evidence: Combined approach reduced pain scores from 7.87 ± 1.19 to 2.40 ± 2.10 at one week, with morphine consumption decreasing from 98.00 ± 34.89 mg to 32.00 ± 28.48 mg. 6
• Infection prevention: Cephazolin 50 mg administered to the disc after phenol injection to prevent discitis. 7

Clinical Context and Patient Selection

When to Consider This Block

According to NCCN guidelines, inferior hypogastric plexus block (often referred to as superior hypogastric plexus block for lower abdominal pain in the guidelines) should be considered for: 3, 4

• Pelvic pain from lower abdominal or pelvic malignancy
• Rectal/perineal pain (often combined with ganglion impar block)
• Patients with inadequate analgesia despite systemic opioid therapy
• Patients experiencing intolerable opioid side effects
• Patients with life expectancy considerations where neurolytic blocks (lasting 3-6 months) are appropriate 8

Contraindications

• Active infection at the injection site 8
• Coagulopathy or bleeding disorders 8
• Very short life expectancy (where benefit may not be realized) 8
• Distorted anatomy that precludes safe needle placement 4

Important Clinical Considerations

Anatomic distinction: The inferior hypogastric plexus is located pre-sacrally and innervates the lower pelvic organs and genitalia, making it distinct from the superior hypogastric plexus (which serves upper pelvic structures). 2 The inferior hypogastric plexus is not readily blocked using paravertebral or transdiscal approaches designed for the superior hypogastric plexus. 2

Combined approach rationale: For patients with both pelvic and perineal pain, combining the inferior hypogastric plexus block with ganglion impar block provides more comprehensive coverage than either block alone, as the ganglion impar specifically innervates the perineum, distal rectum, anus, distal urethra, vulva, and distal third of the vagina. 6

Duration of effect: Neurolytic blocks typically provide pain relief lasting 3-6 months, making them most appropriate for patients with limited life expectancy from advanced malignancy. 8

Multimodal integration: These blocks should be used as adjuvants within a comprehensive pain management strategy, not as standalone therapy, and are typically combined with continued systemic analgesics at reduced doses. 8